<table width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>                     Drug Interactions Associated with Increased Risk of  Myopathy/Rhabdomyolysis (                    <linkhtml href="#dosing3">2.3</linkhtml>,                     <linkhtml href="#dosing4">2.4</linkhtml>,                     <linkhtml href="#contraindications">4</linkhtml>,                     <linkhtml href="#i4i_section_ID_4FD678AF-6EB7-455F-BCB8-E75468F55FF2">5.1</linkhtml>,                     <linkhtml href="#i4i_section_ID_7E1615A3-A89A-4732-AA79-E6D67B4C43DA">7.1</linkhtml>,                     <linkhtml href="#i4i_section_ID_179D3C13-C346-4247-B12B-046258E855CA">7.2</linkhtml>,                     <linkhtml href="#blockers">7.3</linkhtml>,                     <linkhtml href="#i4i_pharmacokinetics_ID_25B1B3F5-7F81-4DB6-A229-FC827A32BB83">12.3</linkhtml>)                                    </caption>
<col width="72%"></col>
<col width="28%"></col>
<thead>
<tr>
<th align="center" stylecode="Botrule Toprule " valign="top">
<content stylecode="bold">Interacting Agents</content>
</th>
<th align="center" stylecode="Botrule Toprule " valign="top">
<content stylecode="bold">Prescribing Recommendations</content>
</th>
</tr>
</thead>
<tbody>
<tr>
<td stylecode="Toprule ">
<paragraph>	  Strong CYP3A4 inhibitors 	  (e.g. itraconazole, ketoconazole, posaconazole, voriconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone cobicistat-containing products), gemfibrozil, cyclosporine, danazol 	</paragraph>
</td>
<td stylecode="Toprule ">
<paragraph>Contraindicated with simvastatin</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>Verapamil, diltiazem, dronedarone</paragraph>
</td>
<td>
<paragraph>Do not exceed 10 mg simvastatin daily</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>Amiodarone, amlodipine, ranolazine</paragraph>
</td>
<td>
<paragraph>Do not exceed 20 mg simvastatin daily</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>Lomitapide</paragraph>
</td>
<td>
<paragraph>For patients with HoFH, do not exceed 20 mg simvastatin daily                           <footnote id="_RefID-11">For patients with HoFH who have been taking 80 mg simvastatin chronically (e.g., for 12 months or more) without evidence of muscle toxicity, do not exceed 40 mg simvastatin when taking lomitapide.</footnote>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule ">
<paragraph>Grapefruit juice</paragraph>
</td>
<td stylecode="Botrule ">
<paragraph>Avoid grapefruit juice </paragraph>
</td>
</tr>
</tbody>
</table>